MedTrace Logo

Mechanisms for Covid-19 Disease Complications

NCT04314232 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-06-26

No results posted yet for this study

Summary

Covid-19 is associated with a wide range of symptoms and clinical trajectories, and early identification of patients at risk for developing severe disease is desirable. Several risk markers and comorbidity profiles have been proposed but their relative importance in unselected patients admitted to hospital with Covid-19 remains unclear. This study aims to assess the prognostic value organ specific biomarkers, viral dynamics and immune response markers in patients infected with SARS-CoV2.

Conditions

  • COVID
  • Coronavirus Infection

Sponsors & Collaborators

  • University Hospital, Akershus

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-18
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04314232 on ClinicalTrials.gov